Skip to main content
Clinical Trials/NCT07636161
NCT07636161Not yet recruitingPhase 4

PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon): A Pilot Randomized Trial of Eroxon® Gel as an Adjunct to Tadalafil in Young Men With Diabetes-Associated Erectile Dysfunction

University of Miami1 site in 1 country30 target enrollmentStarted: September 1, 2026Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Enrollment
30
Locations
1

Study Overview

Brief Summary

The purpose of this research study is to look at whether Eroxon® gel when used together with tadalafil, may help improve erectile function in men ages 18 to 40 who have type 2 diabetes.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Male sex at birth
  • Age 18-40 years
  • Diagnosis of type 2 diabetes mellitus
  • Diagnosis of erectile dysfunction
  • Currently prescribed tadalafil
  • Have a sexual partner willing to complete a survey
  • Ability to provide informed consent

Exclusion Criteria

  • Type 1 diabetes mellitus
  • Severe psychiatric illness that would impair participation
  • Use of nitrates or contraindications to sexual activity
  • Known allergy to Eroxon® gel components
  • Participation in another interventional sexual health study

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sonjia Kenya

Professor of Professional Practice

University of Miami

Study Sites (1)

Loading locations...

Similar Trials